All News about Merck & CoVia Benzinga
Should Investors Buy or Sell the Vaccinex Patent News?
February 07, 2023
Via MarketBeat
Topics
Intellectual Property
Exposures
Intellectual Property
Analyst Upgrades Personalis; Says Biopharma Is Strong, Cash Burn Is Down
February 06, 2023
Via Benzinga
Merck & Co Earnings Preview
February 01, 2023
Via Benzinga
Why Personalis Shares Are Trading Higher Today
February 03, 2023
Via Benzinga
Merck Announces Fourth-Quarter and Full-Year 2022 Financial Results
February 02, 2023
From Merck & Co., Inc.
Via Business Wire
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|